The role of protein kinase C activation in the pathogenesis of diabetic vascular complications

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Park, Joong Yeol ^a   Ha, Sung Woo ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Diabetes; Protein kinase C; Vascular complications

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; CYTOKINE; DIACYLGLYCEROL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; STAUROSPORINE;

BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONFERENCE PAPER; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; IN VIVO STUDY; MUSCLE CONTRACTILITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYNTHESIS; VASCULAR DISEASE;

EID: 0033376607     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s37     Document Type: Conference Paper

References (29)

1. Foster DW. Diabetes mellitus. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill Inc. 1994:1979-2000.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.
3. King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complication. Endocrinol Metab Clin North Am. 1996; 25:255-70.
4. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998; 332:281-92.
5. Shiba T, Inoguchi T, Sportsman JR, Heath W, Bursell S, King GL. Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993; 265:E783-93.
6. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, Bursell S, et al. Preferential elevation of protein kinase isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A. 1992; 89:11059-63.
7. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKCβ inhibitor. Science. 1996; 272:728-31.
8. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol. 1991; 261:F571-7.
9. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994; 43:1122-9.
10. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol. 1994; 267:E369-79.
11. Koya D, Jirousek MR, Lin Y-W, Ishii H, Kubboki K, King GL. Characteristics of protein kinase β-isoform activation on the gene expression of transforming growth factor β, extracellular matrix components and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997; 100:115-26.
12. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose level. Diabetes. 1994; 43:1372-7.
13. +-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest. 1995; 96:733-40.
14. Scheinman JL, Fish AJ, Matas AJ, Michael AF. The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased, and transplanted human kidneys. Am J Pathol. 1978; 90:71-88.
15. Messina JL, Standaert ML, Ishizuka T, Weinstock RS, Farese RV. Role of protein kinase C in insulin's regulation of c-fos transcription. J Biol Chem. 1992; 267: 9223-8.
16. Ruan X, Arendshorst WJ. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol. 1996; 270:F945-52.
17. Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C. Biochem Biophys Res Commun. 1995; 207:80-8.
18. Craven PA, Studer RK, DeRubertis FR. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest. 1994; 93:311-20.
19. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, et al. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol. 1995; 269:E293-6.
20. Bursell SE, Clermont AC, Oren D, King GL. The in vivo effect of endothelin on retinal circulation in non-diabetic and diabetic rats. Invest Ophthalmol Vis Sci. 1995; 36:596-607.
21. Takagi C, Bursell S-E, Lin Y-W, Takaki H, Duh E, Jiang Z, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci. 1996; 37: 2504-18.
22. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990; 267:16-18.
23. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest. 1991; 87: 1643-8.
24. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmanin. J Clin Invest. 1996; 98:894-8.
25. Kuboki K, Jiang ZY, Takahara N, Igarashi M, Yamauchi T, Feener EP, et al. Mechanism of insulin's effect on endothelial nitric oxide synthase (eNOS) expression in vivo and in vitro [Abstract]. Diabetes. 1998;47(Suppl 1):95.
26. Werth DK, Niedel JE, Pastan I. Vinculin, a cytoskeletal substrate of protein kinase C. J Biol Chem. 1983; 258:11423-6.
27. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331: 1480-7.
28. Xia P, Aiello LP, Ishii H, Jiang Z, Park DJ, Robinson GS, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996; 98:2018-26.
29. Koya D, Lee I-K, Ishii H, Kanoh H, King GL. Prevention of glomerular dysfunctions in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol. 1997; 803:426-35.